ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Source:http://linkedlifedata.com/resource/pubmed/id/1347801
Lancet
1992
Mar
28
339
8796
753-70
